Selexipag and Ergocalciferol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Selexipag (selexipag) and Ergocalciferol (ergocalciferol). Common drug interactions include headache among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Selexipag and Ergocalciferol. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.
What is Selexipag?
Selexipag has active ingredients of selexipag. eHealthMe is studying from 2,593 Selexipag users. Check the latest studies of Selexipag.
What is Ergocalciferol?
Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.
26 people who take Selexipag and Ergocalciferol together, and have interactions are studied.

What are the common drug interactions of Selexipag and Ergocalciferol, by gender? *:
female:
- Headache (pain in head)
- Nausea (feeling of having an urge to vomit)
- Pain
- Fatigue (feeling of tiredness)
- Diarrhoea
- Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
- Hypotension (abnormally low blood pressure)
- Vomiting
- Flatulence (flatus expelled through the anus)
- Pain in jaw
male:
- Diarrhoea
- Cough
- Gout (uric acid crystals building up in the body)
- Insomnia (sleeplessness)
- Oxygen saturation decreased
- Pain
- Pulmonary embolism (blockage of the main artery of the lung)
- Renal disorder (kidney disease)
- Death
- Pneumonia
What are the common drug interactions of Selexipag and Ergocalciferol, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Heart rate increased
- Hypersomnia (excessive daytime sleepiness (eds))
- Hypertension (high blood pressure)
- Migraine (headache)
- Nausea (feeling of having an urge to vomit)
- Pain
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Vomiting
50-59:
- Diarrhoea
- Headache (pain in head)
- Malaise (a feeling of general discomfort or uneasiness)
- Fatigue (feeling of tiredness)
- Insomnia (sleeplessness)
- Pain
- Pain in jaw
- Cough
- Decreased appetite
- Dyspnoea (difficult or laboured respiration)
60+:
- Headache (pain in head)
- Nausea (feeling of having an urge to vomit)
- Oxygen saturation decreased
- Chills (felling of cold)
- Dilatation ventricular
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Respiratory syncytial virus infection (viral disease of respiratory system)
- Total lung capacity increased
- Vertigo
- Hypoxia (low oxygen in tissues)
What are the existing conditions these people have? *
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 19 people, 73.08%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 38.46%
- Pain: 3 people, 11.54%
- Interstitial Lung Disease: 3 people, 11.54%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 11.54%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.54%
- Dyspnea (difficult or laboured breathing): 3 people, 11.54%
- Connective Tissue Disorder (any disease that has the connective tissues of the body): 3 people, 11.54%
- Swallowing Difficulty: 2 people, 7.69%
- Stress And Anxiety: 2 people, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Selexipag and Ergocalciferol?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Selexipag (2,593 reports)
- Ergocalciferol (32,652 reports)
Browse all drug interactions of Selexipag and Ergocalciferol:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Selexipag:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ergocalciferol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Selexipag and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ergocalciferol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on selexipag and ergocalciferol (the active ingredients of Selexipag and Ergocalciferol, respectively), and Selexipag and Ergocalciferol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Methotrexate cause Synovial Fluid White Blood Cells Positive? - 3 seconds ago
- Insomnia and Skin Discoloration - Bluish - 9 seconds ago
- Could Mylotarg cause Thrombocytopenia? - 18 seconds ago
- Could Lopurin cause Nervousness? - 39 seconds ago
- Could Rabeprazole Sodium cause Second Primary Malignancy? - 51 seconds ago
- Could Ritalin cause Burning Sensation? - 52 seconds ago
- Drug interactions of Humira and Phenylephrine Hydrochloride - 53 seconds ago
- Drug interactions of Warfarin Sodium and Magnesium Oxide - 58 seconds ago
- Drug interactions of Euthyrox and Flecainide Acetate - 58 seconds ago
- Could Lunesta cause Feeling Drunk? - a minute ago